Trial intelligence / Profile preview

Catgut Embedding for Persistent AF After Ablation

NCT05125042Unknown

Sponsor: Shanghai Chest Hospital
Start: Dec 2021
Primary completion: Jun 2023

Overview

Randomised, single-blind trial (2 arms), sponsored by Shanghai Chest Hospital. Primary endpoint: Postoperative atrial fibrillation (AF)/atrial flutter (AFL)/atrial tachycardia (AT) recurrence rate at 12 months. Status: unknown.

Beyond the preview

Go deeper on NCT05125042.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05125042.